Lipodystrophy for the Diabetologist—What to Look For

N Patni, A Garg - Current diabetes reports, 2022 - Springer
Abstract Purpose of Review Genetic or acquired lipodystrophies are characterized by
selective loss of body fat along with predisposition towards metabolic complications of …

[HTML][HTML] Lipodystrophy syndromes: presentation and treatment

B Akinci, M Sahinoz, E Oral - 2018 - europepmc.org
Lipodystrophy syndromes are a heterogeneous group of diseases, characterized by
selective absence of adipose tissue. In one sense, these diseases are lipid-partitioning …

HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV-1/HAART-associated lipodystrophy

M Giralt, P Domingo, JP Guallar… - Antiviral …, 2006 - journals.sagepub.com
Background The aetiopathogenic bases of HIV-1-/highly active antiretroviral treatment
(HAART)-associated lipodystrophy (HALS) are poorly known, but this syndrome indicates …

Clinical perspectives on HIV-associated lipodystrophy syndrome: an update

A Shevitz, CA Wanke, J Falutz, DP Kotler - Aids, 2001 - journals.lww.com
In developed countries, the availability of highly active antiretroviral therapy (HAART) has
contributed to a dramatic decrease in mortality and opportunistic infections associated with …

Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection.(Featured CME Topic …

LK Tanwani, SPL Mokshagundam - Southern medical journal, 2003 - go.gale.com
The introduction of highly active antiretroviral therapy has significantly reduced morbidity
and mortality in patients infected with the human immunodeficiency virus. Treatment with …

HIV lipodystrophy and its metabolic consequences: implications for clinical practice

AS Wierzbicki, SD Purdon, TC Hardman… - Current Medical …, 2008 - Taylor & Francis
Background: The introduction of highly active antiretroviral therapy (HAART) around 1996
markedly reduced mortality and morbidity from human immunodeficiency virus (HIV) …

Diagnostic strategies and clinical management of lipodystrophy

MC Foss-Freitas, B Akinci, Y Luo… - Expert review of …, 2020 - Taylor & Francis
Introduction: Lipodystrophy is a heterogeneous group of rare diseases characterized by
various degrees of fat loss which leads to serious morbidity due to metabolic abnormalities …

Risk factors for the HIV‐associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatment

S Mauss, M Corzillius, E Wolf, A Schwenk… - HIV …, 2002 - Wiley Online Library
Objective To identify prevalence and risk factors associated with the HIV‐associated
lipodystrophy syndrome (HIVLD) after 3 years of antiretroviral therapy, to investigate the …

[PDF][PDF] NRTI induced mitochondrial toxicity as a mechanism for HAART related lipodystrophy: fact or fiction?

UA Walker, K Brinkman - HIV medicine, 2001 - academia.edu
One of the most debilitating side-effects of long-term highly active antiretroviral therapy
(HAART) is the physical alteration of body composition, also known as lipodystrophy …

Inherited lipodystrophies and hypertriglyceridemia

V Simha, A Garg - Current opinion in lipidology, 2009 - journals.lww.com
Inherited lipodystrophies and hypertriglyceridemia : Current Opinion in Lipidology Inherited
lipodystrophies and hypertriglyceridemia : Current Opinion in Lipidology Log in or Register …